EFFECT OF THE ADMINISTRATION OF ALLOPURINOL ON THE PREVENTION OF MUSCLE MASS LOSS IN IMMOBILIZED SUBJECTS.

Instituo de Investigacion Sanitaria La Fe0 个研究点开始时间: 2011年10月28日最近更新: 2016年10月3日

试验速览

暂无简介。

•Patients with grade II sprain.
•Ages 20 to 40 years.
•Patients not taking regular medication. The concept is understood not to take regular medication to all patients who chronically fail to take any medication in a timely manner regardless of whether they needed to take the last week or last month for a condition treatment on time.
•All patients must have written full informed consent specifically for this study
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 50
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Liver and gastrointestinal disease.
•Hipotiroismo untreated.
•Alcohol and / or substance abuse.
•Vitamin supplements.
•Eating disorders.
•Drugs that lower lipid levels.
•Hypotensive drugs.
•Athletes who perform strenuous exercise.
•Mental disorders, depression or anxiety intensity. These diseases cause the patient unable to understand the nature or scope and possible consequences of the study.
•Patients with any infectious process and / or inflammatory before collecting the sample.
•Patients may not follow the protocol because of its lack of cooperation, inability to return to subsequent visits and there is little chance of completing the study procedures.
•Hypersensitivity to allopurinol.

发起方

Instituo de Investigacion Sanitaria La Fe